The new report titled ‘Global reproductive genetics market , published by Emergen Research, is methodically curated by our team of analysts, keeping readers’ understanding in mind, and includes a wide-ranging database of industry distribution. The report takes a closer look at the historical and current Reproductive Genetics market scenarios to accurately predict the global Reproductive Genetics market outlook over the forecast duration (2020-2028). The report clearly defines the Reproductive Genetics market position on a global level. The detailed insights into the market’s geographical spectrum offered by the report make it an excellent source of knowledge about the Reproductive Genetics industry.
Key players in the market include Illumina, Inc., Agilent Technologies, Inc., PerkinElmer, Inc., Quest Diagnostics, Thermo Fisher Scientific Inc., Fulgent Genetics, Inc., Centogene AG, Myriad Genetics, Inc., Qiagen N.V., and OPKO Health, Inc.
Increasing investment by major companies and rising demand for genetic testing, and improvement in reimbursement policies for medical tests are key growth driving factors
Reproductive Genetics Market Size – USD 4.41 Billion in 2020, Market Growth – at a CAGR of 12.3%, Market Trends – Increasing demand for In vitro fertilization procedures
Get a sample of the report : https://www.emergenresearch.com/request-sample/695
Radical Highlights of the Reproductive Genetics Market Report:
Comprehensive overview of the Reproductive Genetics market along with analysis of the changing dynamics of the market
Growth Assessment of various market segments throughout the forecast period
Regional and global analysis of the market players, including their market share and global position
Growth strategies adopted by key market players to combat the impact of the COVID-19 pandemic on the market
Impact of the technological developments and R&D advancements on the Reproductive Genetics market
Information about profit-making strategies and developmental strategies of major companies and manufacturers
Insightful information for the new entrants willing to enter the market
Details and insights about business expansion strategies, product launches, and other collaborations
The report incorporates advanced analytical tools such as SWOT analysis, Porter’s Five Forces Analysis, feasibility analysis, and investment return analysis
Chromosomal abnormalities are responsible for 50% of miscarriages in first trimester. Reproductive genetics identifies embryos without these abnormalities so that they can be used for IVF, thus increasing the likelihood of healthy pregnancy and baby regardless of patient health. It also helps in achieving higher pregnancy rates per transfer, which reduces the need for IVF and results in low cost, time, and stress.
Advancements in genomic technologies and implementation of these technologies in clinical medicine has expanded their usage in diagnosis of genetic disorders, carrier screening, and identification of cause of infertility. Some tests are quite expensive, which deters couples from going ahead with the tests, but as there is a decline in cost of sequencing and surge in mixed-ethnicity population, an increasing number of couples/individuals are expected to opt for the procedure and this is expected to support market growth going ahead.
Some Key Highlights from the Report
In May 2021, Juno Diagnostics, Which is a company focusing on enhancing access to genetic health information, announced that closing of Series A financing round for USD 25 million led by Perceptive Xontogeny Venture (PXV) Fund. The fund will support product development, clinical validation studies, and commercial launch of JunoDx’s product offerings for non-invasive prenatal testing.
Prenatal screening covers a variety of tests doctors recommend for a pregnant patient. Some prenatal screening tests determines the chances a baby may or may not have chromosomal disorders, such as Down Syndrome. Though recommended by doctors, it is non-invasive and optional, and poses no risk to pregnancy as it involves ultrasound and blood work.
Next Generation Sequencing (NGS) is a widely accepted genetic testing technology in the prenatal testing arena. NGS is able to detect embryos with unbalanced chromosomal translocations that were not identified earlier. NGS offers better coverage of the chromosomes, higher resolution, and is faster and more affordable.
Single gene disorders are among the most understood genetic disorders due to their inheritance patterns and relatively simple genetic causes. Some of the most common single gene disorders are sickle cell anaemia, hemochromatosis, cystic fibrosis, and Tay-Sachs. Reproductive genetic tests are done to detect the possibility of single gene disorders in babies.
Asia Pacific market revenue is expected to register a rapid CAGR during the forecast period due to increasing demand of genetic testing from India and China. In addition, increased utilization of IVF procedures and advancements in the healthcare sector are major factors driving growth of the market in the region.
Emergen Research has segmented the global reproductive genetics market on the basis of product type, procedure type, technology, application, and region:
Product Type Outlook (Revenue, USD Billion; 2018–2028)
- Laboratory Developed Tests (LDT)
- Reagents and Consumables
Procedure Type Outlook (Revenue, USD Billion; 2018–2028)
- Pre-Natal Screening
- Pre-Implantation Genetic Testing
- Infertility Genetic Testing
- Carrier Screening
Technology Outlook (Revenue, USD Billion; 2018–2028)
- Next-Generation Sequencing (NGS)
- Polymerase chain reaction (PCR)
- In-Situ Hybridization (ISH)
Application Outlook (Revenue, USD Billion; 2018–2028)
- Single Gene Disorder
- Structural Chromosomal Abnormality
Regional Analysis of the Reproductive Genetics Market:
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Key Objectives of the Report:
Analysis and estimation of the Reproductive Genetics market size and share for the projected period of 2020-2027
Extensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape
Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Reproductive Genetics market
Analysis of the growth prospects for the stakeholders and investors through the study of the promising segments
Strategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities
Request a discount on the report : https://www.emergenresearch.com/request-for-customization/695
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalnt in the coming decade.
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]